First Mercantile Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

First Mercantile Trust’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$126K	Buy	+208	New	+$129K	0.02%	577
2021 Q1	–	Sell	-341	Closed	-$165K	–	880
2020 Q4	$165K	Buy	+341	New	+$184K	0.02%	508
2020 Q1	–	Sell	-370	Closed	-$139K	–	889
2019 Q4	$139K	Buy	+370	New	+$124K	0.02%	583
2018 Q3	–	Sell	-800	Closed	-$276K	–	944
2018 Q2	$276K	Sell	800 -700	-47%	-$219K	0.06%	405
2018 Q1	$517K	Hold	1,500	–	–	0.11%	241
2017 Q4	$564K	Sell	1,500 -300	-17%	-$122K	0.11%	229
2017 Q3	$805K	Hold	1,800	–	–	0.15%	169
2017 Q2	$884K	Sell	1,800 -800	-31%	-$350K	0.16%	147
2017 Q1	$1.01M	Sell	2,600 -300	-10%	-$111K	0.15%	168
2016 Q4	$1.06M	Sell	2,900 -69	-2%	-$26.2K	0.16%	154
2016 Q3	$1.19M	Sell	2,969 -250	-8%	-$100K	0.16%	171
2016 Q2	$1.12M	Buy	3,219 +350	+12%	+$135K	0.14%	182
2016 Q1	$1.03M	Sell	2,869 -115	-4%	-$47.4K	0.13%	202
2015 Q4	$1.62M	Buy	2,984 +584	+24%	+$316K	0.17%	142
2015 Q3	$1.12M	Hold	2,400	–	–	0.11%	240
2015 Q2	$1.22M	Hold	2,400	–	–	0.1%	254
2015 Q1	$1.08M	Buy	+2,400	New	+$1.02M	0.09%	301
2014 Q2	–	Sell	-260	Closed	-$78K	–	1247
2014 Q1	$78K	Buy	+260	New	+$80.1K	0.01%	947

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

First Mercantile Trust's REGN Position: Q3 2021 in Review

First Mercantile Trust opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2021: 208 shares worth $126K. The stake represents 0.02% of the portfolio and ranks #577 among its holdings. This is a return to the name: First Mercantile Trust previously reported a position in REGN as recently as Q4 2020.

First Mercantile Trust first reported a position in REGN in Q1 2014 and has held it in 18 quarters since. The position peaked at $1.62M in Q4 2015. 1,019 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

First Mercantile Trust held 208 shares of Regeneron Pharmaceuticals worth $126K as of Q3 2021.
Regeneron Pharmaceuticals was a new First Mercantile Trust position in Q3 2021.
Regeneron Pharmaceuticals made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #577 holding.
First Mercantile Trust first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 18 quarters since.
First Mercantile Trust's Regeneron Pharmaceuticals position peaked at $1.62M in Q4 2015.
1,019 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.